4,4'-dihydroxystilbene has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, L; Ferraro, D; Forti, L; Maccario, C; Pizzala, R; Pretali, L; Savio, M; Stivala, LA | 1 |
| Balan, KV; Chen, JC; Chen, SW; Han, Z; Liu, ZL; Pantazis, P; Wang, Y; Wyche, JH; Yang, L; Zheng, LF | 1 |
2 other study(ies) available for 4,4'-dihydroxystilbene and Breast Neoplasms
| Article | Year |
|---|---|
The resveratrol analog 4,4'-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Collagen Type I; Female; Fibroblasts; Humans; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Stilbenes; Tumor Stem Cell Assay; Wound Healing | 2012 |
Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
Topics: Base Sequence; Breast Neoplasms; Cell Line, Tumor; DNA Primers; Down-Regulation; Estradiol; Estrogen Receptor alpha; Humans; Proteasome Endopeptidase Complex; Stilbenes | 2006 |